homologs of the yeast Sir2 protein, SIRT1 to SIRT7 (reviewed in Blander and Guarente, 2004) . The founding member of the sirtuins, Sir2, is essential in yeast for maintaining chromatin in a silent state through the deacetylation of histones. Together, the sirtuins comprise the class III NAD + -dependent histone deacetylases (HDACs) that catalyze NAD + -dependent histone deacetylation, also producing nicotinamide and 2′-O-acetyl-ADP-ribose. However, as each sirtuin has been characterized, an increasing number of exceptions to this classification have been found, including nonhistone sirtuin substrates, the localization of sirtuins outside the nucleus, and the absence of deacetylase activity. The report by Haigis et al. (2006) in this issue of Cell that SIRT4 is a mitochondrial sirtuin regulating glutamate dehydrogenase (GDH) activity through ADP-ribosylation is another example of the biological diversification that is characteristic of this gene family.
The best characterized human Sir2 homolog is SIRT1 (Blander and Guarente, 2004) . SIRT1 is a nuclear protein that deacetylates substrates including histones, NF-κB, p53, FOXO proteins, PPARγ (peroxisome proliferator-activated receptor γ), the HIV Tat protein, and PGC-1α (PPARγ coactivator-1α). SIRT1 regulates cellular processes as diverse as survival under stress, glucose homeostasis, and aging. Although SIRT6 and SIRT7 are also found in the nucleus, they do not colocalize with SIRT1 (Michishita et al., 2005) . In contrast to the euchromatic localization of SIRT1, SIRT6 associates with heterochromatin, whereas SIRT7 is concentrated in the nucleoli. In vitro studies have failed to demonstrate HDAC activity for SIRT6 and SIRT7; however, SIRT6 possesses robust auto-ADP-ribosyltransferase activity. Despite a possible role for SIRT6 in longevity , the exact nature of the enzymatic activities and substrates of SIRT6 and SIRT7 is unknown. SIRT2, found in both the nucleus and cytoplasm, deacetylates proteins such as α-tubulin and regulates mitosis and the cell cycle. In sharp contrast to these sirtuins, SIRT3, SIRT4, and SIRT5 are found principally in the mitochondria (Michishita et al., 2005) . SIRT3 possesses protein deacetylase activity and controls adaptive thermogenesis; the function of SIRT5 is unknown.
SIRT4 is found in the mitochondria of several cell types, including mouse pancreatic β cells. Despite having a conserved sirtuin domain, SIRT4 does not possess detectable deacetylase activity in vitro (Haigis et al., 2006) . Instead, SIRT4 transfers an ADP-ribosyl group from NAD + to histones, an activity that is sensitive to inhibition by nicotinamide (Haigis et al., 2006) .. The mono-ADP-ribosyltransferase activity of SIRT4 is not a complete surprise because, although Sir2 is generally thought to be a NAD + -dependent protein deacetylase, it also possesses weak mono-ADP-ribosyltransferase activity (discussed by Smith and Denu, 2006) .
Posttranslational modification of protein substrates by mono-ADPribosylation involves the creation of an N-or S-glycosidic linkage between a specific amino acid (such as arginine or cysteine) on the acceptor protein and the ADP-ribose residue of NAD + . Several bacterial toxins exhibit mono-ADP-ribosylation activity; in mammalian cells, both intracellular (endo-) and extracellular (ecto-) mono-ADP-ribosyltransferase reactions exist. Several of the intracellular reactions are associated with metabolism and cell signaling, with the β subunit of heterotrimeric G proteins and GRP78/BiP, a chaperone resident in the endoplasmic reticulum, as examples of substrates. The enzyme GDH was the first mitochondrial protein to be identified as being inactivated through mono-ADP-ribosylation (Herrero-Yraola et al., 2001) . Haigis et al. (2006) now identify SIRT4 as the enzyme responsible for the mono-ADP-ribosylation of GDH in vivo.
ADP-ribosylation of proteins can occur in one of two ways: nonenzymatic and enzymatic (Herrero-Yraola et al., 2001 Despite their initial characterization as histone deacetylases controlling transcription, sirtuins also turn out to be critical regulators of metabolism. In this issue of Cell, Haigis et al. (2006) demonstrate that the mammalian Sir2 homolog SIRT4 acts in the mitochondria of pancreatic β cells to repress the activity of glutamate dehydrogenase through ADPribosylation. In this way, SIRT4 downregulates insulin secretion by β cells in response to amino acids.
formed and then reacts nonenzymatically with nucleophilic amino acid residues to form covalent products. Many ADP-ribosyltransferases have inherent NAD + glycohydrolase activity. In the case of enzymatic reactions, ADP-ribose is attached to proteins through the action of an ADP-ribosyltransferase. Given that SIRT4 does not seem to possess glycohydrolase activity, Haigis et al. surmised that SIRT4 may ADP-ribosylate GDH through direct enzymatic transfer of ADP-ribose.
To demonstrate the consequence of this posttranslational modification by SIRT4, the authors tested GDH activity in wild-type mice and mice lacking SIRT4. Pancreatic cell mitochondrial lysates from SIRT4-deficient animals exhibited increased GDH activity. Importantly, the GDH activity in the mitochondrial extracts from SIRT4-deficient mice, unlike control mitochondrial extracts, was unaffected by phosphodiesterase, an enzyme known to cleave ADPribose. This provided strong evidence that GDH activity is inhibited by SIRT4-mediated ADP-ribosylation in vivo. Crucially, Haigis et al. (2006) next demonstrated that a key metabolic consequence of SIRT4-mediated ADP-ribosylation of GDH is the downregulation of insulin secretion in mouse pancreatic β cells in response to amino acids.
In the pancreatic β cell, mitochondria serve to couple nutrient metabolism to the exocytosis of insulin, a process that can be stimulated by glucose or by amino acids (Maechler et al., 2006) . Glucose-stimulated insulin secretion relies on the metabolism of glucose by glycolysis and the tricarboxylic acid cycle (TCA) to generate ATP. An increase in ATP closes ATP-sensitive K + channels, which in turn depolarizes the plasma membrane, thus opening voltagegated L-type Ca 2+ channels, hence facilitating insulin secretion (see Figure 1 ). The mechanism of amino acid-stimulated insulin secretion is less well characterized but is known to involve GDH activity. GDH catalyzes the conversion of glutamate to the TCA-cycle intermediate α-ketoglutarate. In this way, amino acids such as glutamine can be used as a fuel source to generate ATP and to stimulate insulin secretion (Figure 1) . However, GDH is under strict allosteric control, and glutamine (unlike glucose) is not efficiently processed by oxidative metabolism under normal conditions. Glutamine oxidation can be promoted by allosteric activation of GDH by leucine, making leucine a potent insulin secretagogue. GDH sensitivity to leucine is regulated by the cellular GTP/ADP ratio; GDH activity is stimulated by ADP and Lleucine but is blocked by GTP. Thus, under conditions favoring a low GTP/ ADP ratio, such as low glucose, GDH is sensitized to leucine and activated. Thus, leucine-induced GDH stimulation of α-ketoglutarate formation is one mechanism by which amino acids stimulate insulin secretion. The importance of GDH in the control of pancreatic β cell function is underscored by mutations in the regulatory sites of human GDH, which render the enzyme insensitive to allosteric inhibition by GTP, resulting in hyperinsulinemia and hyperammonemia.
SIRT4 may be a new face in the cast of modulators of GDH activity. In pancreatic β cells from SIRT4-deficient mice, GDH is less ADPribosylated and more active, leading to an increase in insulin secretion in response to amino acids. Another exciting observation is that, in SIRT4-deficient animals, glutamine is nearly as effective as leucine in stimulating insulin secretion. This is reminiscent of pancreatic β cells with increased GDH activity (GDH overexpression or expression of dominant-active forms of GDH), which become more responsive to glutamine in terms of insulin secretion (Maechler et al., 2006) . How SIRT4 regulation of GDH Glucose is the most potent stimulator of insulin secretion. Glucose is taken up by the glucose transporters of pancreatic β cells and is metabolized via glycolysis and the TCA cycle, resulting in the formation of ATP. This results in the closure of ATP-dependent K + channels, the opening of voltage-gated L-type Ca 2+ channels, and promotion of insulin secretion by pancreatic β cells. Mitochondrial glutamate dehydrogenase (GDH) controls amino acid-stimulated insulin secretion by regulating glutamine and glutamate oxidative metabolism. Following exposure of the β cell to glutamine and depending on the energy state of the cell, the glutamate formed is converted by GDH to the TCA-cycle intermediate α-ketoglutarate. This promotes mitochondrial activation, ATP generation, and insulin secretion. GDH activity is under the tight control of allosteric effectors-ADP and leucine activate GDH, whereas GTP inhibits it. GDH is also posttranslationally modified by mono-ADP-ribosylation mediated by SIRT4, which blocks GDH's activity and thus prevents amino acid-stimulated insulin secretion.
ADP-ribosylation modulates the responsiveness of β cells to glutamine remains unclear. Furthermore, given that glucose-stimulated insulin secretion is also increased in SIRT4-deficient mice, this mouse model may help to sort out whether glutamate and/or GDH act as an intracellular messenger in this process.
In most tissues, GDH remains inactive (due to GTP inhibition) when cellular energy needs are sufficient (low ADP). However, when cellular energy demands increase, the ADP generated decreases the GTP inhibition, thus permitting glutamate metabolism. In line with this rationale, under conditions of caloric restriction, GDH was found to be less ADPribosylated in pancreatic β cells, and insulin secretion was stimulated by amino acids. Therefore, Haigis et al. propose that caloric restriction downregulates SIRT4 activity and activates a switch to amino acidstimulated insulin secretion. This observation, however, goes against the expectation that sirtuin activity increases during caloric restriction, as is the case for yeast Sir2 (Blander and Guarente, 2004) .
The evolutionary conservation of Sir2 and the sirtuins and their unusual dependence upon NAD + consumption to regulate a rapidly expanding list of cellular processes-from gene silencing to the regulation of longevity-suggests that this class of enzymes may link transcriptional control with energy homeostasis (Blander and Guarente, 2004) . Sirtuin-mediated control of metabolism occurs in a wide range of tissues and involves pleiotropic biological pathways. In white adipose tissue, SIRT1 decreases PPARγ activity and mobilizes free fatty acids (Picard et al., 2004) . SIRT1 represses expression of UCP2 and increases glucosestimulated insulin secretion in pancreatic β cells (Bordone et al., 2006 , Moynihan et al., 2005 . In the liver, SIRT1 regulates gluconeogenesis through deacetylation and activation of the cofactor PGC-1α (Rodgers et al., 2005) . Interestingly, PGC-1α is a master regulator of oxidative phosphorylation and energy homeostasis in mitochondria, the organelles that link energy metabolism and aging. So, it is not unexpected that mitochondrial sirtuins, such as SIRT3 and SIRT4, would also be involved in mitochondrial energy homeostasis. In fact, SIRT3 modulates adaptive thermogenesis in brown adipose tissue, a process confined to mitochondria. Through the regulation of acetyl-CoA synthetases, SIRT3 may also titrate mitochondrial fuel sources. The finding that SIRT4 controls insulin secretion in pancreatic β cells in response to amino acids fits with the notion that sirtuins control the mitochondrial energy supply. These observations, however, raise some evolutionary concerns about the sirtuin gene family. Why has nature permitted evolution of the single Sir2 gene in yeast into a diverse family of paralogs in mammals (Michishita et al., 2005) with distinct enzymatic activities (deacetylation and ADP-ribosylation) that are connected to diverse physiological pathways (DNA stability and metabolism) located in separate cellular compartments (the nucleus and mitochondria)? Furthermore, different sirtuins can have opposing activities on the same physiological pathway, as exemplified by the negative and positive control of insulin secretion by SIRT4 and SIRT1, respectively. This diversification is all the more striking given that all of these activities are controlled by a single metabolite, NAD + . From a mechanistic perspective, it remains unclear what completes the GDH/GDH-ADP-ribose cycle (Herrero-Yraola et al., 2001) . For example, is there an ADP-ribosylhydrolase yet to be identified, or is SIRT4 itself capable of reversing this posttranslational modification? Furthermore, the authors do not completely rule out a substrate-specific deacetylase activity for SIRT4. The fact that many sirtuins remain orphaned in terms of their enzymatic activity, substrates, and regulatory functions suggests that we may be looking in the wrong places. Likewise, the physiological relevance of SIRT4's regulation of insulin secretion in the pancreas needs clarification. Does it play a role in adaptation during feeding or fasting, for example? Could abnormalities in ADP-ribosylation contribute to defects in pancreatic insulin secretion that are characteristic of type 2 diabetes? Further integrative studies should help to define the pleiotropic functions of the remarkable sirtuins and their role in aging, metabolic diseases, and cancer.
